These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27097912)

  • 1. In situ clinical evidence that zinc levels are decreased in breast invasive ductal carcinoma.
    Costello LC; Zou J; Franklin RB
    Cancer Causes Control; 2016 Jun; 27(6):729-35. PubMed ID: 27097912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein expression and zinc levels in invasive ductal breast carcinoma.
    Jin R; Bay B; Tan P; Tan BK
    Oncol Rep; 1999; 6(4):871-5. PubMed ID: 10373673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LKB1 protein expression in human breast cancer.
    Fenton H; Carlile B; Montgomery EA; Carraway H; Herman J; Sahin F; Su GH; Argani P
    Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):146-53. PubMed ID: 16785781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinoma.
    Singh M; Mugler K; Hailoo DW; Burke S; Nemesure B; Torkko K; Shroyer KR
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):417-23. PubMed ID: 21297444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.
    Costello LC; Levy BA; Desouki MM; Zou J; Bagasra O; Johnson LA; Hanna N; Franklin RB
    Cancer Biol Ther; 2011 Aug; 12(4):297-303. PubMed ID: 21613827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc distribution within breast cancer tissue: A possible marker for histological grading?
    Riesop D; Hirner AV; Rusch P; Bankfalvi A
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1321-31. PubMed ID: 25672953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
    Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
    Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone receptor alpha (TRa) tissue expression in ductal invasive breast cancer: A study combining quantitative immunohistochemistry with digital slide image analysis.
    Charalampoudis P; Agrogiannis G; Kontzoglou K; Kouraklis G; Sotiropoulos GC
    Eur J Surg Oncol; 2017 Aug; 43(8):1428-1432. PubMed ID: 28583788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
    Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
    BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
    Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges.
    Wang-Rodriguez J; Dreilinger AD; Alsharabi GM; Rearden A
    Cancer; 2002 Sep; 95(6):1387-95. PubMed ID: 12216108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
    Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
    J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium.
    Cejas P; García-Cabezas MA; Casado E; Barriuso J; Fresno JA; Díaz E; Belda-Iniesta C; Castro J; Espinosa E; Zamora P; Feliu J; Redondo A; Hardisson DA; González-Barón M
    Clin Transl Oncol; 2005 Jul; 7(6):239-43. PubMed ID: 16131446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma.
    Zhu XL; Hartwick W; Rohan T; Kandel R
    Mod Pathol; 1998 Nov; 11(11):1082-8. PubMed ID: 9831206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.